TrialPanorama/TrialPanorama-database huggingface dataset:
Study 28867665 — Predictive Biomarker (PRD): ABCC9 mRNA
Genes: ABCC9; SUR2
Study 28867665 — Predictive Biomarker (PRD): ABCC12 mRNA
Genes: ABCC12; MRP9
Study 28867665 — Predictive Biomarker (PRD): SLC28A1 mRNA
Genes: SLC28A1; CNT1
Study 28867665 — Safety Biomarker (SAF): Peroxisome proliferator-activated receptor delta
Genes: PPARD
Study 28869790 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 28869790 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 28869790 — Predictive Biomarker (PRD): Hormone receptor
Study 28869790 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study 28869931 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 28870611 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 28870611 — Safety Biomarker (SAF): miR-16
Study 28870611 — Safety Biomarker (SAF): miR-15
Study 28870615 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 28870716 — Surrogate Endpoint (SUR): Blood pressure
Study 28871441 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 28872549 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 28874132 — Surrogate Endpoint (SUR): Bone mineral density
Study 28874669 — Predictive Biomarker (PRD): YAP1 mRNA
Genes: YAP1; YAP65
Study 28877686 — Predictive Biomarker (PRD): HOXA3 mRNA
Genes: HOXA3; HOX1E
Study 28877686 — Predictive Biomarker (PRD): HOXA4 mRNA
Genes: HOXA4; HOX1D
Study 28877686 — Predictive Biomarker (PRD): HOXA5 mRNA
Genes: HOXA5; HOX1C
Study 28877686 — Predictive Biomarker (PRD): PBX3 mRNA
Genes: PBX3
Study 28877686 — Predictive Biomarker (PRD): DNMT3A mRNA
Genes: DNMT3A
Study 28877686 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study 28878934 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 28879040 — Surrogate Endpoint (SUR): Blood pressure
Study 28879043 — Surrogate Endpoint (SUR): Bone mineral density
Study 28879248 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study 28879248 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 28879247 — Predictive Biomarker (PRD); Safety Biomarker (SAF): JPH2 mRNA
Genes: JPH2; JP2
Study 28880374 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 28881319 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 28881839 — Predictive Biomarker (PRD): AADAC mRNA
Genes: AADAC; DAC
Study 28882436 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 28882436 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 28883894 — Predictive Biomarker (PRD): MAP3K7 mRNA
Genes: MAP3K7; TAK1
Study 28883894 — Predictive Biomarker (PRD): MYD88 mRNA
Genes: MYD88
Study 28883894 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Interleukin 6 receptor alpha
Genes: IL6R
Study 28883894 — Predictive Biomarker (PRD): RIPK2 mRNA
Genes: RIPK2; CARDIAK; RICK; RIP2; UNQ277/PRO314/PRO34092
Study 28883894 — Predictive Biomarker (PRD): FADD mRNA
Genes: FADD; MORT1; GIG3
Study 28883894 — Safety Biomarker (SAF): Peroxisome proliferator-activated receptor alpha
Genes: PPARA
Study 28885930 — Surrogate Endpoint (SUR): Blood pressure
Study 28887375 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 28889107 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 28892218 — Surrogate Endpoint (SUR): Blood pressure
Study 28894792 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 28898890 — Surrogate Endpoint (SUR): Forced vital capacity
Study 28899363 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study 28899363 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 28899517 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28900115 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study 28900115 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study 28903941 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 28903943 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 28903943 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 28905294 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 28911136 — Predictive Biomarker (PRD): TLR4 mRNA
Genes: TLR4
Study 28911922 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 28911922 — Predictive Biomarker (PRD): DNA excision repair protein ERCC-1
Genes: ERCC1
Study 28912030 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 28912804 — Predictive Biomarker (PRD): HGS mRNA
Genes: HGS; HRS
Study 28912956 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 28916584 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 28916600 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 28916979 — Predictive Biomarker (PRD): P4HB mRNA
Genes: P4HB; ERBA2L; PDI; PDIA1; PO4DB
Study 28917612 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 28917673 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 28919031 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 28919454 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 28921760 — Predictive Biomarker (PRD): CYP2A6 mRNA
Genes: CYP2A6; CYP2A3
Study 28921872 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 28921872 — Predictive Biomarker (PRD): TERT mRNA
Genes: TERT; EST2; TCS1; TRT
Study 28921872 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 28921907 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 28921907 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 28922466 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 28923060 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 28923290 — Predictive Biomarker (PRD): TAS2R60 mRNA
Genes: TAS2R60
Study 28923290 — Predictive Biomarker (PRD): TRPM8 mRNA
Genes: TRPM8; LTRPC6; TRPP8
Study 28923760 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 28923845 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 28924018 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 28924018 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 28925785 — Predictive Biomarker (PRD): NOTCH1 mRNA
Genes: NOTCH1; TAN1
Study 28926513 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 28928173 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28934680 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 28934680 — Predictive Biomarker (PRD): JAK2
Genes: JTK10
Study 28938424 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 28938424 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28938478 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study 28938478 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study 28939374 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28939546 — Surrogate Endpoint (SUR): Blood pressure
Study 28939558 — Predictive Biomarker (PRD): MAPK3 mRNA
Genes: MAPK3; ERK1; PRKM3
Study 28939558 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study 28939688 — Predictive Biomarker (PRD): C1QL1 mRNA
Genes: C1QL1; C1QRF; CRF; CTRP14
Study 28940455 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 28941036 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study 28941620 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): TNF related activation protein
Genes: CD40LG; CD40L; TNFSF5; TRAP
Study 28943279 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 28943493 — Predictive Biomarker (PRD): SFMBT2 mRNA
Genes: SFMBT2; KIAA1617
Study 28943493 — Predictive Biomarker (PRD): SESN3 mRNA
Genes: SESN3; SEST3
Study 28943493 — Predictive Biomarker (PRD): SEC62 mRNA
Genes: SEC62; TLOC1
Study 28944714 — Predictive Biomarker (PRD): GLS2 mRNA
Genes: GLS2; GA
Study 28945848 — Monitoring Biomarker (MOI): Cell-free DNA
Study 28945911 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 28945911 — Predictive Biomarker (PRD): FCGR3B
Genes: CD16; CD16b; FcgammaRIIIb; FcRIIIb
Study 28948656 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 28950146 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 28950146 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 28950288 — Predictive Biomarker (PRD): MAP2K1 mRNA
Genes: MAP2K1; MEK1; PRKMK1
Study 28950290 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 28950290 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 28950298 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 28950309 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 28950338 — Predictive Biomarker (PRD): NRG1 mRNA
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study 28950338 — Predictive Biomarker (PRD): SDC4 mRNA
Genes: SDC4
Study 28950338 — Predictive Biomarker (PRD): ATP1B1 mRNA
Genes: ATP1B1; ATP1B
Study 28950372 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 28950889 — Monitoring Biomarker (MOI): Mitochondrial frataxin
Genes: FXN; FRDA; X25
Study 28951660 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 28952191 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study 28954004 — Surrogate Endpoint (SUR): Blood pressure
Study 28954285 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 28954285 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 28954285 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 28954285 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 28954285 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 28954285 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 28954781 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 28955494 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 28955496 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28956082 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study 28956082 — Predictive Biomarker (PRD): CHGA mRNA
Genes: CHGA
Study 28956082 — Predictive Biomarker (PRD): GCG mRNA
Genes: GCG
Study 28956082 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 28956082 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study 28956082 — Predictive Biomarker (PRD): PCSK1 mRNA
Genes: PCSK1; NEC1
Study 28956082 — Predictive Biomarker (PRD): PCSK2 mRNA
Genes: PCSK2; NEC2
Study 28958347 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 28958801 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study 28958801 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 28959122 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 28959500 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 28960096 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 28961812 — Predictive Biomarker (PRD): CTRC mRNA
Genes: CTRC; CLCR
Study 28961847 — Predictive Biomarker (PRD): DNA mismatch repair protein MSH2
Genes: MSH2
Study 28961847 — Predictive Biomarker (PRD): Forkhead box protein P3
Genes: FOXP3; IPEX; JM2
Study 28962047 — Predictive Biomarker (PRD): DST mRNA
Genes: DST; BP230; BP240; BPAG1; DMH; DT; KIAA0728
Study 28962047 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 28964326 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 28964701 — Monitoring Biomarker (MOI): HBV DNA
Study 28964736 — Predictive Biomarker (PRD): LDLR mRNA
Genes: LDLR
Study 28964736 — Predictive Biomarker (PRD): APOB mRNA
Genes: APOB
Study 28964736 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 28965093 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 28965185 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 28965778 — Safety Biomarker (SAF): BDNF
Study 28970100 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 28970192 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 28971223 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 28971900 — Predictive Biomarker (PRD): MTOR
Genes: RAFT1; RAPT1; FLJ44809
Study 28972011 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 28972913 — Surrogate Endpoint (SUR): Blood pressure
Study 28973026 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 28973026 — Surrogate Endpoint (SUR): Serum calcium
Study 28973026 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 28973091 — Predictive Biomarker (PRD): PVR mRNA
Genes: PVR; PVS
Study 28973164 — Safety Biomarker (SAF): miR-375
Genes: MIR375
Study 28973223 — Surrogate Endpoint (SUR): Bone mineral density
Study 28973223 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 28973403 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 28973622 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 28976556 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 28976556 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study 28976817 — Predictive Biomarker (PRD): ABCD1 mRNA
Genes: ABCD1; ALD
Study 28976817 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 28978551 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 28978797 — Predictive Biomarker (PRD): TACR1 mRNA
Genes: TACR1; NK1R; TAC1R
Study 28978797 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 28978797 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study 28980004 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 28980198 — Surrogate Endpoint (SUR): Blood pressure
Study 28980446 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 28981994 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 28981994 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study 28981994 — Surrogate Endpoint (SUR): Serum testosterone
Study 28982159 — Surrogate Endpoint (SUR): Blood pressure
Study 28982374 — Predictive Biomarker (PRD): PTBP2 mRNA
Genes: PTBP2; NPTB; PTB; PTBLP
Study 28982667 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 28982765 — Predictive Biomarker (PRD): ARCN1 mRNA
Genes: ARCN1; COPD
Study 28982765 — Predictive Biomarker (PRD): SH2D2A mRNA
Genes: SH2D2A; SCAP; TSAD; VRAP
Study 28983018 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 28983166 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 28983800 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study 28983800 — Predictive Biomarker (PRD): PKD2 mRNA
Genes: PKD2; TRPP2
Study 28985241 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 28985241 — Predictive Biomarker (PRD): PCSK6 mRNA
Genes: PCSK6; PACE4
Study 28985241 — Surrogate Endpoint (SUR): Blood pressure
Study 28987002 — Surrogate Endpoint (SUR): Bone mineral density
Study 28989060 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 28991404 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28991900 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 28991900 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study 29016235 — Predictive Biomarker (PRD): HPN mRNA
Genes: HPN; TMPRSS1
Study 29016998 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 29016998 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 29016998 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 29017461 — Predictive Biomarker (PRD): TF mRNA
Genes: TF; PRO1400
Study 29017994 — Surrogate Endpoint (SUR): Blood pressure
Study 29018174 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 29018526 — Surrogate Endpoint (SUR): Forced vital capacity
Study 29018537 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study 29018537 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study 29018537 — Monitoring Biomarker (MOI): Complement C4
Study 29018564 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29020217 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29020221 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study 29020221 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29020221 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 29020286 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 29020286 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study 29020361 — Monitoring Biomarker (MOI): HBV DNA
Study 29020998 — Predictive Biomarker (PRD): SHMT2 mRNA
Genes: SHMT2
Study 29020998 — Predictive Biomarker (PRD): SLC1A5 mRNA
Genes: SLC1A5; ASCT2; M7V1; RDR; RDRC
Study 29023473 — Predictive Biomarker (PRD): VASP mRNA
Genes: VASP
Study 29024428 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29025008 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 29025008 — Surrogate Endpoint (SUR): Forced vital capacity
Study 29025767 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 29027195 — Predictive Biomarker (PRD): TSPYL1 mRNA
Genes: TSPYL1; TSPYL
Study 29027195 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CYP17A1 mRNA
Genes: CYP17A1; CYP17; S17AH
Study 29027195 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 29027195 — Predictive Biomarker (PRD): TSPYL5 mRNA
Genes: TSPYL5; KIAA1750
Study 29028662 — Predictive Biomarker (PRD): TSC2
Genes: tuberin; LAM; PPP1R160
Study 29028662 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29028933 — Surrogate Endpoint (SUR): Blood pressure
Study 29029190 — Surrogate Endpoint (SUR): Bone mineral density
Study 29030346 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 29030361 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29030421 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SLC6A4 mRNA
Genes: SLC6A4; HTT; SERT
Study 29030717 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29032136 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 29032136 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 29033369 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 29033827 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 29034366 — Predictive Biomarker (PRD): CSF1R mRNA
Genes: CSF1R; FMS
Study 29036345 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study 29036345 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 29036630 — Predictive Biomarker (PRD): SCNN1A mRNA
Genes: SCNN1A; SCNN1
Study 29036630 — Predictive Biomarker (PRD): SCNN1G mRNA
Genes: SCNN1G
Study 29036630 — Surrogate Endpoint (SUR): Blood pressure
Study 29037448 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 29037983 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 29038168 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 29038338 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 29038891 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 29040162 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29041979 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29042364 — Predictive Biomarker (PRD): CD200R1 mRNA
Genes: CD200R1; CD200R; CRTR2; MOX2R; OX2R; UNQ2522/PRO6015
Study 29042364 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study 29042364 — Predictive Biomarker (PRD): CD200 mRNA
Genes: CD200; MOX1; MOX2; My033
Study 29042492 — Predictive Biomarker (PRD): MCIDAS mRNA
Genes: MCIDAS; IDAS; MCI; MCIN
Study 29043263 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study 29045487 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study 29045540 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 29045540 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 29045543 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 29045543 — Predictive Biomarker (PRD): Hormone receptor
Study 29047161 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 29047161 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29051021 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study 29052073 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study 29052782 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 29054589 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 29054833 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 29054923 — Predictive Biomarker (PRD): NFATC2 mRNA
Genes: NFATC2; NFAT1; NFATP
Study 29054923 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 29055890 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29056470 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 29056570 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1